HBV-induced liver cirrhosis patients exhibit elevated levels of S100A8/A9, natural killer (NK) cells, and interferon-gamma (IFN-γ) following STAT3 activation, a biomarker profile associated with diabetes development (Li et al., 2024). The gene discussed is S100A8; the disease is diabetes mellitus.